Stergios Boussios

ORCID: 0000-0002-2512-6131 · 7 papers in corpus · active 2020-2025

Study types

  • review 1

Condition tags

  • endometriosis 1
  • infertility 1
2025
Cureus ·doi:10.7759/cureus.92089

BackgroundThe diagnostic process in dermatology often hinges on visual recognition and clinical pattern matching, making it an attractive field for the application of artificial intelligence (AI). Large language models (LLMs) like ChatGPT-4…

2023
Current treatment options in oncology ·doi:10.1007/s11864-023-01138-4

Opinion statementOvarian carcinosarcoma (OCS), also known as a malignant mixed Müllerian tumour (MMMT), is a rare and aggressive form of cancer that accounts for less than 5% of ovarian cancers. It is characterized by high morbidity and mor…

2022
International journal of environmental research and public health ·doi:10.3390/ijerph19031106

Non-epithelial ovarian cancers (NEOC) are a group of uncommon malignancies that mainly includes germ cell tumours (GCT), sex cord-stromal tumours (SCST), and some extremely rare tumours, such as small cell carcinomas and sarcomas. Each of t…

2022
International journal of environmental research and public health ·doi:10.3390/ijerph19148577

Ovarian cancer is one of the most common gynecologic cancers and has the highest mortality rate of any other cancer of the female reproductive system. Epithelial ovarian cancer (EOC) accounts for approximately 90% of all ovarian malignancie…

review 2020
Annals of translational medicine ·doi:10.21037/atm-20-3022a

Abstract: Endometriosis is a benign gynecologic condition affecting up to one woman out of ten of reproductive age. It is defined by the presence of endometrial-like tissue in localizations outside of the uterine cavity. It often causes sym…

2020
Annals of translational medicine ·doi:10.21037/atm-2020-oc-14
2020
Journal of personalized medicine ·doi:10.3390/jpm10020041

Epithelial ovarian cancer (EOC) is the fifth leading cause of cancer mortality among women. Two-thirds of patients present at advanced stage at diagnosis, and the estimated 5 year survival rate is 20-40%. This heterogeneous group of maligna…